_id
6919e95c3c536f8df23182b4
Ticker
HVO.LSE
Name
hVIVO plc
Exchange
LSE
Address
40 Bank Street, London, United Kingdom, E14 5NR
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.hvivo.com
Description
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, the company offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, it provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company offers services to big pharma and biotech organizations. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Last Close
63000
Volume
519520
Current Price
6.179
Change
0
Last Updated
2025-12-30T11:03:31.368Z
Image
https://logo.clearbit.com/www.hvivo.com
Ipo Date
-
Market Cap
42332516
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.86
Strong Buy
1
Buy
4
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
25445000
Cost Of Revenue
22427000
Gross Profit
3018000
Operating Expenses
3388000
Operating Income
-370000
Interest Expense
-
Pretax Income
-138000
Net Income
-110000
Eps
-0.00015966568815017464
Dividends Per Share
1372000
Shares Outstanding
687216180
Income Tax Expense
28000
EBITDA
3018000
Operating Margin
-1.4541167223423068
Total Other Income Expense Net
232000
Cash
23288000
Short Term Investments
-
Receivables
4542000
Inventories
1759000
Total Current Assets
42410000
Property Plant Equipment
21459000
Total Assets
85672000
Payables
2169000
Short Term Debt
2503000
Long Term Debt
-
Total Liabilities
42043000
Equity
43629000
Bs_currency_symbol
-
Depreciation
1953000
Change In Working Capital
-342000
Cash From Operations
-7528000
Capital Expenditures
575000
Cash From Investing
-10356000
Cash From Financing
-2951000
Net Change In Cash
23288000
Cf_currency_symbol
-
PE
6.16
PB
97.5717342871943
ROE
-0.2521258795755117
ROA
-0.12839667569334207
FCF
-8103000
Fcf Percent
-0.3184515621929652
Piotroski FScore
0
Health Score
22
Deep Value Investing Score
6.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
6
Net Net Investing Score
3.5
Quality Investing Score
2.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
25445000
Quarters > 0 > income Statement > cost Of Revenue
22427000
Quarters > 0 > income Statement > gross Profit
3018000
Quarters > 0 > income Statement > operating Expenses
3388000
Quarters > 0 > income Statement > operating Income
-370000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-138000
Quarters > 0 > income Statement > net Income
-110000
Quarters > 0 > income Statement > eps
-0.00015966568815017464
Quarters > 0 > income Statement > dividends Per Share
1372000
Quarters > 0 > income Statement > shares Outstanding
688939504
Quarters > 0 > income Statement > income Tax Expense
28000
Quarters > 0 > income Statement > EBITDA
3018000
Quarters > 0 > income Statement > operating Margin
-1.4541167223423068
Quarters > 0 > income Statement > total Other Income Expense Net
232000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
23288000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4542000
Quarters > 0 > balance Sheet > inventories
1759000
Quarters > 0 > balance Sheet > total Current Assets
42410000
Quarters > 0 > balance Sheet > property Plant Equipment
21459000
Quarters > 0 > balance Sheet > total Assets
85672000
Quarters > 0 > balance Sheet > payables
2169000
Quarters > 0 > balance Sheet > short Term Debt
2503000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
42043000
Quarters > 0 > balance Sheet > equity
43629000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-110000
Quarters > 0 > cash Flow > depreciation
1953000
Quarters > 0 > cash Flow > change In Working Capital
-342000
Quarters > 0 > cash Flow > cash From Operations
-7528000
Quarters > 0 > cash Flow > capital Expenditures
575000
Quarters > 0 > cash Flow > cash From Investing
-10356000
Quarters > 0 > cash Flow > cash From Financing
-2951000
Quarters > 0 > cash Flow > net Change In Cash
23288000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00015966568815017464
Quarters > 0 > ratios > PB
97.5717342871943
Quarters > 0 > ratios > ROE
-0.2521258795755117
Quarters > 0 > ratios > ROA
-0.12839667569334207
Quarters > 0 > ratios > FCF
-8103000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.3184515621929652
Quarters > 0 > health Score
22
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
25532000
Quarters > 1 > income Statement > cost Of Revenue
-28459000
Quarters > 1 > income Statement > gross Profit
53991000
Quarters > 1 > income Statement > operating Expenses
48024000
Quarters > 1 > income Statement > operating Income
5967000
Quarters > 1 > income Statement > interest Expense
955000
Quarters > 1 > income Statement > pretax Income
6137000
Quarters > 1 > income Statement > net Income
5394000
Quarters > 1 > income Statement > eps
0.00783721177193494
Quarters > 1 > income Statement > dividends Per Share
1000
Quarters > 1 > income Statement > shares Outstanding
688254976
Quarters > 1 > income Statement > income Tax Expense
743000
Quarters > 1 > income Statement > EBITDA
9069000
Quarters > 1 > income Statement > operating Margin
23.370672097759673
Quarters > 1 > income Statement > total Other Income Expense Net
170000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
44180000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
13957000
Quarters > 1 > balance Sheet > inventories
804000
Quarters > 1 > balance Sheet > total Current Assets
60229000
Quarters > 1 > balance Sheet > property Plant Equipment
19299000
Quarters > 1 > balance Sheet > total Assets
88893000
Quarters > 1 > balance Sheet > payables
1884000
Quarters > 1 > balance Sheet > short Term Debt
2510000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
44218000
Quarters > 1 > balance Sheet > equity
44675000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
8031000
Quarters > 1 > cash Flow > depreciation
1714000
Quarters > 1 > cash Flow > change In Working Capital
954000
Quarters > 1 > cash Flow > cash From Operations
7716000
Quarters > 1 > cash Flow > capital Expenditures
628000
Quarters > 1 > cash Flow > cash From Investing
1216000
Quarters > 1 > cash Flow > cash From Financing
-1810000
Quarters > 1 > cash Flow > net Change In Cash
44119500
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.00783721177193494
Quarters > 1 > ratios > PB
95.19255728492445
Quarters > 1 > ratios > ROE
12.073866815892558
Quarters > 1 > ratios > ROA
6.067969356417266
Quarters > 1 > ratios > FCF
7088000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.2776124079586401
Quarters > 1 > health Score
73
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
37193000
Quarters > 2 > income Statement > cost Of Revenue
28459000
Quarters > 2 > income Statement > gross Profit
8734000
Quarters > 2 > income Statement > operating Expenses
1845000
Quarters > 2 > income Statement > operating Income
6889000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
7152000
Quarters > 2 > income Statement > net Income
5258000
Quarters > 2 > income Statement > eps
0.00762918891695625
Quarters > 2 > income Statement > dividends Per Share
1359000
Quarters > 2 > income Statement > shares Outstanding
689195150
Quarters > 2 > income Statement > income Tax Expense
1894000
Quarters > 2 > income Statement > EBITDA
8734000
Quarters > 2 > income Statement > operating Margin
18.522302583819535
Quarters > 2 > income Statement > total Other Income Expense Net
263000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
37094000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
19035000
Quarters > 2 > balance Sheet > inventories
340000
Quarters > 2 > balance Sheet > total Current Assets
57817000
Quarters > 2 > balance Sheet > property Plant Equipment
20247000
Quarters > 2 > balance Sheet > total Assets
87745000
Quarters > 2 > balance Sheet > payables
1585000
Quarters > 2 > balance Sheet > short Term Debt
1359000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
49281000
Quarters > 2 > balance Sheet > equity
38464000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
5258000
Quarters > 2 > cash Flow > depreciation
1845000
Quarters > 2 > cash Flow > change In Working Capital
-4668000
Quarters > 2 > cash Flow > cash From Operations
2620000
Quarters > 2 > cash Flow > capital Expenditures
1832000
Quarters > 2 > cash Flow > cash From Investing
-1876000
Quarters > 2 > cash Flow > cash From Financing
-595000
Quarters > 2 > cash Flow > net Change In Cash
60500
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.00762918891695625
Quarters > 2 > ratios > PB
110.71487187629992
Quarters > 2 > ratios > ROE
13.669925124792012
Quarters > 2 > ratios > ROA
5.992364237278477
Quarters > 2 > ratios > FCF
788000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.021186782459064878
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
18596500
Quarters > 3 > income Statement > cost Of Revenue
14229500
Quarters > 3 > income Statement > gross Profit
4367000
Quarters > 3 > income Statement > operating Expenses
922500
Quarters > 3 > income Statement > operating Income
3444500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
3576000
Quarters > 3 > income Statement > net Income
2629000
Quarters > 3 > income Statement > eps
0.003814594458478125
Quarters > 3 > income Statement > dividends Per Share
679500
Quarters > 3 > income Statement > shares Outstanding
689195150
Quarters > 3 > income Statement > income Tax Expense
947000
Quarters > 3 > income Statement > EBITDA
4367000
Quarters > 3 > income Statement > operating Margin
18.522302583819535
Quarters > 3 > income Statement > total Other Income Expense Net
131500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
2629000
Quarters > 3 > cash Flow > depreciation
922500
Quarters > 3 > cash Flow > change In Working Capital
-2334000
Quarters > 3 > cash Flow > cash From Operations
1310000
Quarters > 3 > cash Flow > capital Expenditures
916000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-297500
Quarters > 3 > cash Flow > net Change In Cash
60500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.003814594458478125
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
394000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.021186782459064878
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
62725000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
62725000
Annuals > 0 > income Statement > operating Expenses
49869000
Annuals > 0 > income Statement > operating Income
12856000
Annuals > 0 > income Statement > interest Expense
1112000
Annuals > 0 > income Statement > pretax Income
13289000
Annuals > 0 > income Statement > net Income
10652000
Annuals > 0 > income Statement > eps
0.01547682235718409
Annuals > 0 > income Statement > dividends Per Share
1358000
Annuals > 0 > income Statement > shares Outstanding
688254976
Annuals > 0 > income Statement > income Tax Expense
2637000
Annuals > 0 > income Statement > EBITDA
17803000
Annuals > 0 > income Statement > operating Margin
20.49581506576325
Annuals > 0 > income Statement > total Other Income Expense Net
433000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
44180000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
13957000
Annuals > 0 > balance Sheet > inventories
804000
Annuals > 0 > balance Sheet > total Current Assets
60229000
Annuals > 0 > balance Sheet > property Plant Equipment
19299000
Annuals > 0 > balance Sheet > total Assets
88893000
Annuals > 0 > balance Sheet > payables
1884000
Annuals > 0 > balance Sheet > short Term Debt
2510000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
44218000
Annuals > 0 > balance Sheet > equity
44675000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
13289000
Annuals > 0 > cash Flow > depreciation
3559000
Annuals > 0 > cash Flow > change In Working Capital
-3714000
Annuals > 0 > cash Flow > cash From Operations
10336000
Annuals > 0 > cash Flow > capital Expenditures
2460000
Annuals > 0 > cash Flow > cash From Investing
-660000
Annuals > 0 > cash Flow > cash From Financing
-2405000
Annuals > 0 > cash Flow > net Change In Cash
7207000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
0.01547682235718409
Annuals > 0 > ratios > PB
95.67013768237268
Annuals > 0 > ratios > ROE
23.843312814773363
Annuals > 0 > ratios > ROA
11.98294578875727
Annuals > 0 > ratios > FCF
7876000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.12556396970904743
Annuals > 0 > health Score
74
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
56043000
Annuals > 1 > income Statement > cost Of Revenue
45629000
Annuals > 1 > income Statement > gross Profit
10414000
Annuals > 1 > income Statement > operating Expenses
45941000
Annuals > 1 > income Statement > operating Income
10102000
Annuals > 1 > income Statement > interest Expense
176000
Annuals > 1 > income Statement > pretax Income
11147000
Annuals > 1 > income Statement > net Income
16115000
Annuals > 1 > income Statement > eps
0.023496483324426224
Annuals > 1 > income Statement > dividends Per Share
3054000
Annuals > 1 > income Statement > shares Outstanding
685847315
Annuals > 1 > income Statement > income Tax Expense
-4968000
Annuals > 1 > income Statement > EBITDA
14018000
Annuals > 1 > income Statement > operating Margin
18.025444747782952
Annuals > 1 > income Statement > total Other Income Expense Net
1045000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
36973000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
13200000
Annuals > 1 > balance Sheet > inventories
426000
Annuals > 1 > balance Sheet > total Current Assets
52004000
Annuals > 1 > balance Sheet > property Plant Equipment
20038000
Annuals > 1 > balance Sheet > total Assets
83228000
Annuals > 1 > balance Sheet > payables
2088000
Annuals > 1 > balance Sheet > short Term Debt
367000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
48902000
Annuals > 1 > balance Sheet > equity
34326000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
11147000
Annuals > 1 > cash Flow > depreciation
2716000
Annuals > 1 > cash Flow > change In Working Capital
4102000
Annuals > 1 > cash Flow > cash From Operations
17239000
Annuals > 1 > cash Flow > capital Expenditures
5177000
Annuals > 1 > cash Flow > cash From Investing
-5177000
Annuals > 1 > cash Flow > cash From Financing
-4704000
Annuals > 1 > cash Flow > net Change In Cash
8529000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
0.023496483324426224
Annuals > 1 > ratios > PB
124.07830292343995
Annuals > 1 > ratios > ROE
46.94692070150906
Annuals > 1 > ratios > ROA
19.362474167347525
Annuals > 1 > ratios > FCF
12062000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.21522759309815678
Annuals > 1 > health Score
76
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
48477000
Annuals > 2 > income Statement > cost Of Revenue
44473000
Annuals > 2 > income Statement > gross Profit
4004000
Annuals > 2 > income Statement > operating Expenses
42335000
Annuals > 2 > income Statement > operating Income
6023000
Annuals > 2 > income Statement > interest Expense
133000
Annuals > 2 > income Statement > pretax Income
-365000
Annuals > 2 > income Statement > net Income
-776000
Annuals > 2 > income Statement > eps
-0.0011565795280075854
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
670943918
Annuals > 2 > income Statement > income Tax Expense
411000
Annuals > 2 > income Statement > EBITDA
2698000
Annuals > 2 > income Statement > operating Margin
12.424448707634548
Annuals > 2 > income Statement > total Other Income Expense Net
-6388000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
28444000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
9343290
Annuals > 2 > balance Sheet > inventories
499000
Annuals > 2 > balance Sheet > total Current Assets
42234000
Annuals > 2 > balance Sheet > property Plant Equipment
3123000
Annuals > 2 > balance Sheet > total Assets
51380000
Annuals > 2 > balance Sheet > payables
2701000
Annuals > 2 > balance Sheet > short Term Debt
1652000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
31162000
Annuals > 2 > balance Sheet > equity
20218000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-365000
Annuals > 2 > cash Flow > depreciation
2930000
Annuals > 2 > cash Flow > change In Working Capital
7015000
Annuals > 2 > cash Flow > cash From Operations
15981000
Annuals > 2 > cash Flow > capital Expenditures
1362000
Annuals > 2 > cash Flow > cash From Investing
-1362000
Annuals > 2 > cash Flow > cash From Financing
-1834000
Annuals > 2 > cash Flow > net Change In Cash
12750000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.0011565795280075854
Annuals > 2 > ratios > PB
206.08179497378572
Annuals > 2 > ratios > ROE
-3.838164012266297
Annuals > 2 > ratios > ROA
-1.5103152977812377
Annuals > 2 > ratios > FCF
14619000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.30156569094622193
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
36864000
Annuals > 3 > income Statement > cost Of Revenue
963000
Annuals > 3 > income Statement > gross Profit
35901000
Annuals > 3 > income Statement > operating Expenses
35605000
Annuals > 3 > income Statement > operating Income
590000
Annuals > 3 > income Statement > interest Expense
227000
Annuals > 3 > income Statement > pretax Income
277000
Annuals > 3 > income Statement > net Income
-74000
Annuals > 3 > income Statement > eps
-0.00011041689176231839
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
670187313
Annuals > 3 > income Statement > income Tax Expense
351000
Annuals > 3 > income Statement > EBITDA
3069000
Annuals > 3 > income Statement > operating Margin
1.6004774305555556
Annuals > 3 > income Statement > total Other Income Expense Net
-313000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
15694000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8089000
Annuals > 3 > balance Sheet > inventories
659000
Annuals > 3 > balance Sheet > total Current Assets
25335000
Annuals > 3 > balance Sheet > property Plant Equipment
3715000
Annuals > 3 > balance Sheet > total Assets
42274000
Annuals > 3 > balance Sheet > payables
2055000
Annuals > 3 > balance Sheet > short Term Debt
2285000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
21594000
Annuals > 3 > balance Sheet > equity
20680000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
277000
Annuals > 3 > cash Flow > depreciation
2565000
Annuals > 3 > cash Flow > change In Working Capital
-1774000
Annuals > 3 > cash Flow > cash From Operations
-1564000
Annuals > 3 > cash Flow > capital Expenditures
739000
Annuals > 3 > cash Flow > cash From Investing
-739000
Annuals > 3 > cash Flow > cash From Financing
-1195000
Annuals > 3 > cash Flow > net Change In Cash
-3511000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.00011041689176231839
Annuals > 3 > ratios > PB
201.25063896179884
Annuals > 3 > ratios > ROE
-0.3578336557059961
Annuals > 3 > ratios > ROA
-0.17504849316364668
Annuals > 3 > ratios > FCF
-2303000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.06247287326388889
Annuals > 3 > health Score
16
Valuation > metrics > PE
6.16
Valuation > metrics > PB
97.5717342871943
Valuation > final Score
40
Valuation > verdict
1557.0% Overvalued
Profitability > metrics > ROE
-0.2521258795755117
Profitability > metrics > ROA
-0.25937278943645364
Profitability > metrics > Net Margin
-0.004323049715071723
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9636480322721126
Risk > metrics > Interest Coverage
-0.11723700887198986
Risk > final Score
48
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.07748287671233
Liquidity > metrics > Quick Ratio
8.700984589041095
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
70
Prev Profitabilities > 0
81
Prev Profitabilities > 1
76
Prev Profitabilities > 2
56
Prev Risks > 0
73
Prev Risks > 1
47
Prev Risks > 2
47
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T23:02:00.252Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-08
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-08
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0028
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-02
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-25
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-19
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-06-07
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-20
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-06-17
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-30
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.02
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-05-15
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.05
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-06-30
Earnings History > 10 > report Date
2018-09-10
Earnings History > 10 > date
2018-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-03-31
Earnings History > 11 > report Date
2018-06-06
Earnings History > 11 > date
2018-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.02
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.02
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-06-30
Earnings History > 12 > report Date
2017-09-12
Earnings History > 12 > date
2017-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2016-12-31
Earnings History > 13 > report Date
2017-03-31
Earnings History > 13 > date
2016-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.02
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-06-30
Earnings History > 14 > report Date
2016-09-28
Earnings History > 14 > date
2016-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-03-31
Earnings History > 15 > report Date
2016-05-26
Earnings History > 15 > date
2016-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
-
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, the company offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, it provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company offers services to big pharma and biotech organizations. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUK life sciences services spotlight featuring hVIVO plc across FTSE AIM All-Share - Kalkine Media
12/16/2025
UK life sciences services spotlight featuring hVIVO plc across FTSE AIM All-Share Kalkine Media
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
4
Hold
2
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of hVIVO plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
0.0028
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.